Terms: = Pancreatic cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM
66 results:
1. GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas.
Lennartz M; Benjamin Dünnebier N; Höflmayer D; Dwertmann Rico S; Kind S; Reiswich V; Viehweger F; Lutz F; Fraune C; Gorbokon N; Luebke AM; Hube-Magg C; Büscheck F; Menz A; Uhlig R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Steurer S; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C
Am J Surg Pathol; 2024 Apr; 48(4):377-386. PubMed ID: 38271200
[TBL] [Abstract] [Full Text] [Related]
2. Pathologic tumor response to neoadjuvant therapy in resected pancreatic cancer: does it affect prognosis?
Donisi G; Nappo G; Pacilli M; Capretti GL; Spaggiari P; Sollai M; Bozzarelli S; Zerbi A
Updates Surg; 2023 Sep; 75(6):1497-1508. PubMed ID: 37578734
[TBL] [Abstract] [Full Text] [Related]
3. Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study.
Wen C; Zhang L; Yang Y; Jin Y; Ren D; Zhang Z; Zou S; Li F; Sun H; Jin J; Lu X; Xie J; Cheng D; Xu Z; Chen H; Mao B; Zhang J; Wang J; Deng X; Peng C; Li H; Jiang C; Lin L; Zhang H; Chen H; Shen B; Zhan Q
Int J Surg; 2023 Jul; 109(7):1941-1952. PubMed ID: 37026827
[TBL] [Abstract] [Full Text] [Related]
4. Teledentistry: A Future Solution in the Diagnosis of Oral Lesions: Diagnostic Meta-Analysis and Systematic Review.
Uhrin E; Domokos Z; Czumbel LM; Kói T; Hegyi P; Hermann P; Borbély J; Cavalcante BGN; Németh O
Telemed J E Health; 2023 Nov; 29(11):1591-1600. PubMed ID: 36976779
[No Abstract] [Full Text] [Related]
5. The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study.
Yang L; Su J; Wang W; Zhou F
World J Surg Oncol; 2023 Jan; 21(1):19. PubMed ID: 36691032
[TBL] [Abstract] [Full Text] [Related]
6. Surgical and oncological outcomes of robotic- versus laparoscopic-assisted distal gastrectomy with D2 lymphadenectomy for advanced gastric cancer: a propensity score‑matched analysis of 1164 patients.
Gao G; Liao H; Jiang Q; Liu D; Li T
World J Surg Oncol; 2022 Sep; 20(1):315. PubMed ID: 36171631
[TBL] [Abstract] [Full Text] [Related]
7. A preponderance of gastrointestinal cancer patients transition into cachexia syndrome.
Gilmore LA; Olaechea S; Gilmore BW; Gannavarapu BS; Alvarez CM; Ahn C; Iyengar P; Infante RE
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2920-2931. PubMed ID: 36165100
[TBL] [Abstract] [Full Text] [Related]
8. Investigating Causal Associations of Diet-Derived Circulating Antioxidants with the Risk of Digestive System cancers: A Mendelian Randomization Study.
Zhang X; Zhao H; Man J; Yin X; Zhang T; Yang X; Lu M
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956413
[TBL] [Abstract] [Full Text] [Related]
9. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
10. Sarcopenia as an Independent Risk Factor for Specific cancers: A Propensity Score-Matched Asian Population-Based Cohort Study.
Sun MY; Chang CL; Lu CY; Wu SY; Zhang JQ
Nutrients; 2022 May; 14(9):. PubMed ID: 35565877
[TBL] [Abstract] [Full Text] [Related]
11. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM
Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165
[TBL] [Abstract] [Full Text] [Related]
12. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.
Lee SH; Yim SY; Jeong YS; Li QX; Kang SH; Sohn BH; Kumar SV; Shin JH; Choi YR; Shim JJ; Kim H; Kim JH; Kim S; Guo S; Johnson RL; Kaseb A; Kang KJ; Chun YS; Jang HJ; Lee BG; Woo HG; Ha MJ; Akbani R; Roberts LR; Wheeler DA; Lee JS
Hepatology; 2022 Dec; 76(6):1634-1648. PubMed ID: 35349735
[TBL] [Abstract] [Full Text] [Related]
13. Knockdown of long non-coding MIR210HG inhibits cell proliferation, migration, and invasion in hepatoblastoma via the microRNA-608-FOXO6 axis.
Duan Y; Wu H; Hao X; Li F; Liu J; Zhu C; Dong Q
J Int Med Res; 2021 Dec; 49(12):3000605211054695. PubMed ID: 34918962
[TBL] [Abstract] [Full Text] [Related]
14. Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort.
Zhan Q; Wen C; Zhao Y; Fang L; Jin Y; Zhang Z; Zou S; Li F; Yang Y; Wu L; Jin J; Lu X; Xie J; Cheng D; Xu Z; Zhang J; Wang J; Deng X; Chen H; Peng C; Li H; Zhang H; Fang H; Wang C; Shen B
EBioMedicine; 2021 Dec; 74():103716. PubMed ID: 34839264
[TBL] [Abstract] [Full Text] [Related]
15. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples.
Jansen K; Farahi N; Büscheck F; Lennartz M; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Clauditz T; Bernreuther C; Dum D; Krech T; Marx A; Steurer S
Pathol Res Pract; 2021 Dec; 228():153663. PubMed ID: 34717148
[TBL] [Abstract] [Full Text] [Related]
16. MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples.
Rico SD; Mahnken M; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Möller-Koop C; Fraune C; Möller K; Menz A; Bernreuther C; Jacobsen F; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Minner S; Burandt E; Krech T; Marx AH
Technol Cancer Res Treat; 2021; 20():15330338211043328. PubMed ID: 34547930
[No Abstract] [Full Text] [Related]
17. INR and not bilirubin levels predict postoperative morbidity in patients with malignant obstructive jaundice.
Scheufele F; Aichinger L; Jäger C; Demir IE; Schorn S; Demir E; Sargut M; Friess H; Ceyhan GO
Am J Surg; 2021 Nov; 222(5):976-982. PubMed ID: 34001332
[TBL] [Abstract] [Full Text] [Related]
18. Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis.
Cai Y; Wang X; Wang N; Wu J; Ma L; Xie X; Zhang H; Dang C; Kang H; Zhang S; Zhou Z
Life Sci; 2021 Jul; 277():119505. PubMed ID: 33872662
[TBL] [Abstract] [Full Text] [Related]
19. Outcomes of Complex Gastrointestinal cancer Resection at US News & World Report Top-Ranked vs Non-Ranked Hospitals.
Tay E; Gambhir S; Stopenski S; Hohmann S; Smith BR; Daly S; Hinojosa MW; Nguyen NT
J Am Coll Surg; 2021 Jul; 233(1):21-27.e1. PubMed ID: 33752982
[TBL] [Abstract] [Full Text] [Related]
20. Long-term Metabolic Morbidity and Steatohepatosis Following Standard pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis.
Beger HG; Mayer B; Vasilescu C; Poch B
Ann Surg; 2022 Jan; 275(1):54-66. PubMed ID: 33630451
[TBL] [Abstract] [Full Text] [Related]
[Next]
